Edition:
India

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

8.86USD
25 Apr 2018
Change (% chg)

-- (--)
Prev Close
$8.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,127
52-wk High
$15.75
52-wk Low
$5.48

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 1 5.00 5.00 5.00 --
Year Ending Apr-18 1 8.60 8.60 8.60 --
Year Ending Apr-19 1 14.40 14.40 14.40 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 1 -0.26 -0.26 -0.26 --
Year Ending Apr-18 1 -1.74 -1.74 -1.74 --
Year Ending Apr-19 1 -1.59 -1.59 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.65 32.31
P/E High - Last 5 Yrs. -- 40.53 46.12
P/E Low - Last 5 Yrs. -- 23.87 24.71
Beta -- 0.80 0.79
Price to Sales (TTM) 27.05 4.37 7.14
Price to Book (MRQ) 3.35 3.79 4.88
Price to Tangible Book (MRQ) 3.47 4.69 6.49
Price to Cash Flow (TTM) -- 21.39 24.37
% Owned Institutions 66.87 1.22 2.32

Dividends

  Company industry sector
Dividend Yield -- 1.68 1.58
Dividend Yield - 5 Year Avg -- 0.76 0.78
Dividend 5 Year Growth Rate -- 2.85 4.08
Payout Ratio(TTM) -- 20.95 21.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 839.92 7.02 9.18
Sales (TTM) vs TTM 1 Yr. Ago 1,263.57 9.89 11.01
Sales - 5 Yr. Growth Rate -- 7.67 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 51.40 20.70 23.62
EPS (TTM) vs TTM 1 Yr. Ago 80.06 -- --
EPS - 5 Yr. Growth Rate -- 9.09 10.39
Capital Spending - 5 Yr. Growth Rate -- 9.75 10.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.51 2.52
Current Ratio (MRQ) 2.73 3.57 3.58
LT Debt to Equity (MRQ) 0.41 8.89 11.61
Total Debt to Equity (MRQ) 1.19 11.22 14.31
Interest Coverage (TTM) -30.32 36.66 30.88

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.94 54.20
Gross Margin - 5 Yr. Avg. -- 52.32 52.34
EBITD Margin (TTM) -563.85 -- --
EBITD - 5 Yr. Avg -- 18.46 15.90
Operating Margin (TTM) -567.67 12.86 3.62
Operating Margin - 5 Yr. Avg. -- 14.17 11.17
Pre-Tax Margin (TTM) -527.54 13.10 4.27
Pre-Tax Margin - 5 Yr. Avg. -- 14.53 11.48
Net Profit Margin (TTM) -527.54 9.51 0.90
Net Profit Margin - 5 Yr. Avg. -- 10.85 7.81
Effective Tax Rate (TTM) -- 22.46 31.67
Effective Tax Rate - 5 Yr. Avg. -- 23.68 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 892,442,880 786,924,448
Net Income/Employee (TTM) -- 104,727,878 92,306,248
Receivable Turnover (TTM) 0.89 5.53 5.48
Inventory Turnover (TTM) -- 2.53 3.46
Asset Turnover (TTM) 0.07 0.90 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -36.96 10.76 10.35
Return on Assets - 5 Yr. Avg. -- 11.98 11.38
Return on Investment (TTM) -49.99 13.36 12.97
Return on Investment - 5 Yr. Avg. -- 15.50 14.74
Return on Equity (TTM) -61.02 15.09 14.84
Return on Equity - 5 Yr. Avg. -- 16.72 16.08
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.87%
# of Holders: 32
Total Shares Held: 7,219,373
3 Mo. Net Change: 371
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.